Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$7.9 - $21.32 $1.85 Million - $4.98 Million
233,552 Added 196.37%
352,485 $7.51 Million
Q4 2023

Feb 14, 2024

BUY
$2.48 - $9.65 $294,953 - $1.15 Million
118,933 New
118,933 $1.14 Million
Q2 2023

Aug 14, 2023

SELL
$3.47 - $5.33 $47,445 - $72,877
-13,673 Reduced 30.5%
31,154 $145,000
Q1 2023

May 15, 2023

BUY
$3.03 - $5.13 $135,825 - $229,962
44,827 New
44,827 $168,000

Others Institutions Holding FUSN

About Fusion Pharmaceuticals Inc.


  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.